Principles that give your cell and gene therapy startup a good chance at success.

It is a great privilege to have Dr Robin Quirk, Vice President, Technology Sourcing & Venture Development, CCRM (Toronto, Canada), to share his reflections on creating viable CGT startups. Robin leads the team responsible for identifying and developing promising technologies and nurturing them to the company creation stage by strategically leveraging CCRM’s expertise and infrastructure.

Next
Next

Proud to announce the publication of the CCRM Australia 2025 Impact Report.